Alerts will be sent to your verified email
Verify Email
WOCKPHARMA
|
Wockhardt
|
Pfizer
|
Eris Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-3.51 % | 19.03 % | 17.74 % |
|
5yr Avg Net Profit Margin
|
-4.28 % | 26.04 % | 22.76 % |
|
Price to Book
|
5.29 | 5.57 | 8.49 |
|
P/E
|
0.0 | 29.06 | 62.59 |
|
5yr Avg Cash Conversion Cycle
|
-94.15 Days | 21.86 Days | -54.68 Days |
|
5yr Average Interest Coverage Ratio
|
-0.43 | 185.18 | 66.44 |
|
5yr Avg ROCE
|
-0.28 % | 23.84 % | 18.34 % |
|
5yr Avg Operating Profit Margin
|
5.03 % | 31.72 % | 34.43 % |
|
5 yr average Debt to Equity
|
0.56 | 0.0 | 0.46 |
|
5yr CAGR Net Profit
|
n/a | 76.68 % | -0.19 % |
|
5yr Average Return on Assets
|
-1.79 % | 15.25 % | 12.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.09 % | 63.92 % | 54.83 % |
|
Share Pledged by Promoters
|
15.64 % | 0.0 | 16.93 % |
|
Change in Promoter Holding (3 Yrs)
|
-16.66 % | 0.0 | 2.53 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.99 % | 4.53 % | 6.42 % |
|
Wockhardt
|
Pfizer
|
Eris Lifesciences
|
|---|